Anthem Biosciences Limited

SBI Mutual Fund bought 98,88,996 shares of Anthem Biosciences, representing a 1.76% stake. The acquisition was part of a larger block deal where several investors acquired a combined 3.05% stake from promoter Aruna Ganesh for ₹1,274.69 crore at ₹744.80 per share.

A biotechnology company providing contract research, development, and manufacturing services alongside specialty ingredients production. Established in 2006, the company serves pharmaceutical and nutraceutical sectors through its integrated CRDMO capabilities and custom synthesis expertise. Its distinctive position lies in combining comprehensive development expertise with in-house manufacturing facilities, enabling end-to-end solutions for clients requiring specialized ingredient formulation, process optimization, and commercial-scale production services.

India's largest AMC by total AUM, managing over Rs 11 lakh crore across equity, debt and hybrid schemes. Backed by State Bank of India, the country's largest bank, which gives it unmatched retail reach across every Indian state. With over 70 schemes and 50 million folios, SBI MF's positioning moves are tracked as a proxy for domestic institutional flows.